Dr. Woyach on the Role of Acalabrutinib in CLL Published 2020-09-10 Download video MP4 360p Download video MP4 720p Recommendations 14:45 Management of Adverse Effects in R/R HER2+ mBC 08:36 Julie Ann Freischlag shares her journey as a woman surgeon | Ohio State College of Medicine 01:30 How smoking affects your voice | Ohio State Medical Center 02:03 Clinical Social Workers | Compassionate Advocates. Collaborative Leaders. 03:16 Dr. Richard Hammer and navify® Tumor Board 02:39 Degenerative disc disease surgery: Beth’s story | Ohio State Medical Center 03:24 Ohio Help Me Grow Home Visiting 17:00 Psychosis & Schizophrenia Mnemonics (Memorable Psychiatry Lecture) 02:48 Socratic Questioning in Cognitive Therapy 03:06 Educating Patients on Maintenance Therapy in mUC 01:29 Role of Hospital Social Workers 19:20 FDA-approved Therapies for Relapsed/Refractory HER2+ mBC 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 11:04 Cluster B (Borderline, Antisocial, Narcissistic, Histrionic) Personality Disorders 1:09:45 Living With Polycythemia Vera 14:00 Bladder cancer detection and treatment | Ohio State Medical Center 01:33 Treating Dystonia through deep brain stimulation 02:28 Dr Vaz Batista on Treating Patients With HER2+ Breast Cancer and Leptomeningeal Carcinomatosis 01:20 Providers Want Better Training on LGBTQ Populations 02:28 Central Scheduling Delivers Best Outcomes With Every Patient Appointment They Make Similar videos 01:20 Dr. Woyach on 3-Year Follow-Up of Acalabrutinib/Obinutuzumab Combo in CLL 01:03 Dr. Woyach on the Safety of Acalabrutinib Versus Ibrutinib in CLL 01:25 Dr. Woyach on the Role of Chemoimmunotherapy in CLL 01:08 Dr. Woyach on the Role of Small Molecule Inhibitors in CLL 07:19 Acalabrutinib’s Role in Treating Chronic Lymphocytic Leukemia 01:17 Dr. Woyach on Treatment Challenges in CLL 01:47 Dr. Woyach on Ibrutinib Resistance in CLL 01:41 Dr. Logan Discusses Acalabrutinib in CLL 01:22 Combined acalabrutinib treatments for CLL 01:16 Dr. Woyach on Ibrutinib and Peripheral Lymphocytosis in Patients with Chronic Lymphocytic Leukemia 01:46 Dr. Woyach on Frontline Treatment Options in CLL 02:00 Dr. Barrientos Discusses Acalabrutinib in CLL 01:46 Acalabrutinib Shows Promising Results for the Treatment of CLL 01:13 Dr. Eradat Discusses Data With Acalabrutinib in CLL 00:55 Dr. Woyach on the Results of the ELEVATE-TN Trial 01:21 Dr. Woyach on Clinical Trials Examining Novel Triplets in CLL 01:25 Dr. Abedin Discusses Differences Between Acalabrutinib and Ibrutinib in CLL 02:37 Resistance to acalabrutinib in CLL is mediated by BTK mutations 00:50 Dr. Furman on Acalabrutinib Monotherapy in CLL More results